Journal of Biological Chemistry · 2003 · 102 citations · 57 references
Life SciencesCell BiologyMolecular BiologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceApoptotic SignalingCell DeathApoptosis After IrradiationApoptotic Signaling In CancerCancer Cell ApoptosisChemotherapy-induced ApoptosisParp InhibitionPoly(adp-ribose) Polymerase InhibitionPoly(adp-ribose) Polymerase InhibitorsRadiation-induced Apoptosis
Molecular defects in apoptotic pathways are thought to often contribute to the abnormal expansion of malignant cells and their resistance to chemotherapy. Therefore, a comprehensive knowledge of the mechanisms controlling induction of apoptosis and subsequent cellular disintegration could result in improved methods for prognosis and treatment of cancer. In this study, we have examined apoptosis-induced alterations in two proteins, nucleolin and poly(ADP-ribose) polymerase-1 (PARP-1), in U937 leukemia cells. Nucleolin is expressed at high levels in malignant cells, and it is a multifunctional and mobile protein that can shuttle among the nucleolus, nucleoplasm, cytoplasm, and plasma membrane. Here, we report our findings that UV irradiation or camptothecin treatment of U937 cells induced apoptosis and caused a significant change in the levels and localization of nucleolin within the nucleus. Additionally, nucleolin levels were dramatically decreased in extracts containing the cytoplasm and plasma membrane. These alterations could be abrogated by pre-incubation with an inhibitor of PARP-1 (3-aminobenzamide), and our data support a potential role for nucleolin in removing cleaved PARP-1 from dying cells. Furthermore, both nucleolin and cleaved PARP-1 were detected in the culture medium of cells undergoing apoptosis, associated with particles of a size consistent with apoptotic bodies. These results indicate that nucleolin plays an important role in apoptosis, and could be a useful marker for assessing apoptosis or detecting apoptotic bodies. In addition, the data provide a possible explanation for the appearance of nucleolin and PARP-1 autoantibodies in some autoimmune diseases. Molecular defects in apoptotic pathways are thought to often contribute to the abnormal expansion of malignant cells and their resistance to chemotherapy. Therefore, a comprehensive knowledge of the mechanisms controlling induction of apoptosis and subsequent cellular disintegration could result in improved methods for prognosis and treatment of cancer. In this study, we have examined apoptosis-induced alterations in two proteins, nucleolin and poly(ADP-ribose) polymerase-1 (PARP-1), in U937 leukemia cells. Nucleolin is expressed at high levels in malignant cells, and it is a multifunctional and mobile protein that can shuttle among the nucleolus, nucleoplasm, cytoplasm, and plasma membrane. Here, we report our findings that UV irradiation or camptothecin treatment of U937 cells induced apoptosis and caused a significant change in the levels and localization of nucleolin within the nucleus. Additionally, nucleolin levels were dramatically decreased in extracts containing the cytoplasm and plasma membrane. These alterations could be abrogated by pre-incubation with an inhibitor of PARP-1 (3-aminobenzamide), and our data support a potential role for nucleolin in removing cleaved PARP-1 from dying cells. Furthermore, both nucleolin and cleaved PARP-1 were detected in the culture medium of cells undergoing apoptosis, associated with particles of a size consistent with apoptotic bodies. These results indicate that nucleolin plays an important role in apoptosis, and could be a useful marker for assessing apoptosis or detecting apoptotic bodies. In addition, the data provide a possible explanation for the appearance of nucleolin and PARP-1 autoantibodies in some autoimmune diseases. poly(ADP-ribose) polymerase-1 3-aminobenzamide phosphate-buffered saline 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide terminal dUTP nick-end labeling phosphate-buffered saline plus Tween 20 systemic lupus erythematosus Following treatment with chemotherapy agents or exposure to cellular stress such as heat shock or ionizing radiation, malignant cells can respond by undergoing apoptosis or necrosis, or may be resistant to treatment. The failure of malignant cells to undergo cell death in response to chemotherapy is a major cause of treatment failure (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar), and, in many cases, chemoresistance is associated with aberrant expression of the proteins involved in the activation and regulation of apoptosis (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar, 2Saikumar P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar, 3Gascoyne R.D. Adomat S.A. Krajewski S. Krajewska M. Horsman D.E. Tolcher A.W. O'Reilly S.E. Hoskins P. Coldman A.J. Reed J.C. Connors J.M. Blood. 1997; 90: 244-251Google Scholar). Consequently, several therapeutic strategies based on modulating apoptotic pathways are currently in development (4Johnstone R.W. Ruefli A.A. Lowe S.W. Cell. 2002; 108: 153-164Google Scholar, 5Makin G. Expert Opin. Ther. Targets. 2002; 6: 73-84Google Scholar).Apoptosis is characterized by well defined morphological and biochemical changes, which are generally mediated by a family of cysteine proteases, called caspases. There are at least two well characterized molecular mechanisms leading to caspase-dependent apoptosis, namely receptor-mediated and mitochondrial pathways, which have been described in some detail in recent reviews (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar, 2Saikumar P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar). Both pathways lead to activation of caspase-3, which ultimately results in fragmentation of chromosomal DNA and proteolysis of selected nuclear proteins. The aim of the present study is to investigate the role of nucleolin during apoptosis of leukemia cells treated with the chemotherapy agent, camptothecin, or irradiated with UV light, and to examine the relationship between changes in nucleolin and effects on poly(ADP-ribose) polymerase-1 (PARP-1).1Human nucleolin is a 707-amino acid protein consisting of an acidic histone-like N terminus, a central domain containing four RNA binding domains, and a C terminus that is rich in arginine and glycine (RGG repeats). This multidomain structure reflects the diverse roles of nucleolin in cell growth, proliferation, and death, which have been recently highlighted in several excellent reviews (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar). Nucleolin been in many cellular and of and of cell and apoptosis (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar, J. Scholar, J. G. J. 2001; Scholar, M. J. Scholar, J. 1999; Scholar, V. P. Scholar, S. J. Scholar). generally a nucleolin to be mobile and can be present in the and cytoplasm and on the cell J. Scholar, J. G. J. 2001; Scholar, Cell. Scholar, S. G. M. 1999; Scholar, J. G. J. S. J. Scholar, S. J. Scholar, V. P. V. 1999; Scholar). In are several of nucleolin within the cell in response to a of heat shock J. Scholar, J. G. J. 2001; Scholar), J. Scholar), cell activation J. 2001; Scholar), treatment with a inhibitor 1999; Scholar), and J. 2001; Scholar, S. P. J. Scholar, G. M. M. G. M. G. G. Blood. 2001; is in nucleolin it is involved in many of the of nucleolin expression in malignant cells. of nucleolin are with cellular M. V. and high levels of proteins which nucleolin is the major a prognosis in many of M. Scholar). have nucleolin as a for therapeutic based on our that that to nucleolin protein can and apoptosis in many cell from J. 1999; Scholar, J. 2001; Scholar, V. 2002; and Blood. levels and of PARP-1 protein have been examined in this study for two PARP-1 is a of apoptosis and the of is often to the of PARP-1 it been that nucleolin can a with PARP-1 in M. J. and in cells M. 2001; Scholar), that PARP-1 could be involved in the regulation of nucleolin or the of poly(ADP-ribose) to a of nuclear proteins in response to DNA is that this plays an role in DNA response and apoptosis S. J. 1999; Scholar, S. M. Scholar). PARP-1 is binding to DNA and is in response to cellular such as heat radiation, exposure to and treatment with chemotherapy of poly(ADP-ribose) and of PARP-1 during apoptosis is thought to to and of which is for of This to be a of the apoptotic and appearance of the and of PARP-1 of the of apoptosis S. J. 1999; Scholar, S. M. we the of apoptosis in U937 leukemia cells on the expression of nucleolin and PARP-1 proteins. nucleolin can between cellular alterations in nucleolin in both nuclear the and and the cytoplasm and plasma extracts have been are a of nucleolin and regulation is of nucleolin is a protein of and to within the the for have been (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar). nucleolin is associated with many of the that are in cells cell and levels of nucleolin expression are generally to M. V. Scholar, M. Scholar). we have nucleolin as the molecular of a of that the of and leukemia cell and have significant as therapeutic agents J. 1999; Scholar, J. 2001; Scholar, V. 2002; Scholar, Blood. this we have described alterations in the levels and localization of nucleolin protein that in leukemia cells induced to undergo apoptosis by or treatment with the that induction of apoptosis by a in the levels of nuclear several by the of nucleolin from the containing plasma of nucleolin within the and the appearance of apoptotic containing nucleolin and PARP-1 were levels and localization of nucleolin in to apoptosis-induced changes, we have that alterations in nucleolin in the apoptotic at UV irradiation of cells fragmentation of DNA is on and of PARP-1 been the levels of nuclear nucleolin are a in the of nuclear nucleolin can be and levels of apoptotic can be detected and and data The that alterations in nucleolin are such an may indicate that this protein plays an role in the or of apoptosis, be to have been several that have examined the role of nucleolin in cell M. J. Cell. Scholar, M. G. J. Cell. 2001; Scholar, M. G. P. J. Cell. 2001; have and to examine changes in proteins in leukemia cells treated with camptothecin or These a with fragmentation of of nucleolin in apoptotic cells cells, and that nucleolin during apoptosis, in with our In to our results and of and several that nucleolin is in response to S. J. to nucleolin as a protein that cleaved in response to apoptosis in a cell S. J. Med. 2001; described the proteolysis of a protein to be to a or cells were treated with J. that nucleolin a for by an by The findings apoptosis-induced of nucleolin could be caused by cell death the apoptotic pathways for treatment are from it to that DNA as UV irradiation or camptothecin could a from which to S. J. Scholar), or which is to S. S. apoptosis-induced changes in nucleolin levels that we have described to in some as an inhibitor of PARP-1 can be to this is to of nucleolin by or the binding of nucleolin to the of PARP-1 In with our have described of PARP-1 in response to apoptosis G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar). PARP-1 can be in the some G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar, S. Scholar), and is some to that the is central to the of apoptosis and the of proteolysis M. G. V. M. J. J. J. 2001; Scholar, J. result of our study is the that nucleolin to be from apoptotic cells in the of bodies. J. described apoptotic in and several of have been M. FASEB J. Scholar, Z. Scholar). are thought to be from which are to the plasma and the are by Med. 2001; Scholar). apoptotic have been are to several DNA or plasma and nuclear proteins M. G. P. J. Cell. 2001; Scholar, Z. of nucleolin in apoptotic a of In apoptotic are by or cells, and from the of apoptosis, apoptotic may be the Med. 2001; and could be detected in plasma or This apoptosis can be caused by a of autoimmune and cancer. There is that the of apoptotic cells or can be an important or marker for several of Scholar, J. Scholar, 2002; Scholar, M. J. J. 2001; and of apoptotic or in been as a to the of or to therapeutic response in chemotherapy or S. P. M. J. 2001; Scholar, 2001; Scholar). Nucleolin may be a useful marker for apoptosis in apoptotic are to be rich in The of apoptotic to their to the cells that is an which been to the of M. S. 2001; 98: Scholar, J. G. Blood. 1999; and as a J. Reed J.M. 2002; data have for some autoimmune which are thought to at least in of defects in apoptotic P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar, Med. 2001; Scholar). are characterized by the development of and and is that this response could be by exposure of the to of from apoptotic cells G. J. Med. Scholar, Am. Scholar, M. S. P. J. 2001; Scholar, J. 2002; Scholar). The appearance of nucleolin autoantibodies is of the of the autoimmune systemic lupus erythematosus and are in some of the autoantibodies to as the S. J. Scholar, M. J. S. Scholar). that apoptotic containing nucleolin are from cells undergoing apoptosis a possible explanation for the appearance of nucleolin autoantibodies in with have a high of PARP-1 autoantibodies S. J. 2002; our have nucleolin as an important of the apoptotic in leukemia cells. we have role in this our results indicate that nucleolin may be involved in the of a of Furthermore, the nuclear of from the plasma and in apoptotic may be useful to apoptosis in and Following treatment with chemotherapy agents or exposure to cellular stress such as heat shock or ionizing radiation, malignant cells can respond by undergoing apoptosis or necrosis, or may be resistant to treatment. The failure of malignant cells to undergo cell death in response to chemotherapy is a major cause of treatment failure (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar), and, in many cases, chemoresistance is associated with aberrant expression of the proteins involved in the activation and regulation of apoptosis (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar, 2Saikumar P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar, 3Gascoyne R.D. Adomat S.A. Krajewski S. Krajewska M. Horsman D.E. Tolcher A.W. O'Reilly S.E. Hoskins P. Coldman A.J. Reed J.C. Connors J.M. Blood. 1997; 90: 244-251Google Scholar). Consequently, several therapeutic strategies based on modulating apoptotic pathways are currently in development (4Johnstone R.W. Ruefli A.A. Lowe S.W. Cell. 2002; 108: 153-164Google Scholar, 5Makin G. Expert Opin. Ther. Targets. 2002; 6: 73-84Google Scholar). is characterized by well defined morphological and biochemical changes, which are generally mediated by a family of cysteine proteases, called caspases. There are at least two well characterized molecular mechanisms leading to caspase-dependent apoptosis, namely receptor-mediated and mitochondrial pathways, which have been described in some detail in recent reviews (1Schimmer A.D. Hedley D.W. Penn L.Z. Minden M.D. Blood. 2001; 98: 3541-3553Google Scholar, 2Saikumar P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar). Both pathways lead to activation of caspase-3, which ultimately results in fragmentation of chromosomal DNA and proteolysis of selected nuclear proteins. The aim of the present study is to investigate the role of nucleolin during apoptosis of leukemia cells treated with the chemotherapy agent, camptothecin, or irradiated with UV light, and to examine the relationship between changes in nucleolin and effects on poly(ADP-ribose) polymerase-1 nucleolin is a 707-amino acid protein consisting of an acidic histone-like N terminus, a central domain containing four RNA binding domains, and a C terminus that is rich in arginine and glycine (RGG repeats). This multidomain structure reflects the diverse roles of nucleolin in cell growth, proliferation, and death, which have been recently highlighted in several excellent reviews (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar). Nucleolin been in many cellular and of and of cell and apoptosis (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar, J. Scholar, J. G. J. 2001; Scholar, M. J. Scholar, J. 1999; Scholar, V. P. Scholar, S. J. Scholar). generally a nucleolin to be mobile and can be present in the and cytoplasm and on the cell J. Scholar, J. G. J. 2001; Scholar, Cell. Scholar, S. G. M. 1999; Scholar, J. G. J. S. J. Scholar, S. J. Scholar, V. P. V. 1999; Scholar). In are several of nucleolin within the cell in response to a of heat shock J. Scholar, J. G. J. 2001; Scholar), J. Scholar), cell activation J. 2001; Scholar), treatment with a inhibitor 1999; Scholar), and J. 2001; Scholar, S. P. J. Scholar, G. M. M. G. M. G. G. Blood. 2001; Scholar). There is in nucleolin it is involved in many of the of nucleolin expression in malignant cells. of nucleolin are with cellular M. V. and high levels of proteins which nucleolin is the major a prognosis in many of M. Scholar). have nucleolin as a for therapeutic based on our that that to nucleolin protein can and apoptosis in many cell from J. 1999; Scholar, J. 2001; Scholar, V. 2002; and Blood. Scholar). The levels and of PARP-1 protein have been examined in this study for two PARP-1 is a of apoptosis and the of is often to the of PARP-1 it been that nucleolin can a with PARP-1 in M. J. and in cells M. 2001; Scholar), that PARP-1 could be involved in the regulation of nucleolin or PARP-1 the of poly(ADP-ribose) to a of nuclear proteins in response to DNA is that this plays an role in DNA response and apoptosis S. J. 1999; Scholar, S. M. Scholar). PARP-1 is binding to DNA and is in response to cellular such as heat radiation, exposure to and treatment with chemotherapy of poly(ADP-ribose) and of PARP-1 during apoptosis is thought to to and of which is for of This to be a of the apoptotic and appearance of the and of PARP-1 of the of apoptosis S. J. 1999; Scholar, S. M. Scholar). Here, we the of apoptosis in U937 leukemia cells on the expression of nucleolin and PARP-1 proteins. nucleolin can between cellular alterations in nucleolin in both nuclear the and and the cytoplasm and plasma extracts have been are a of nucleolin and regulation is of nucleolin is a protein of and to within the the for have been (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar). nucleolin is associated with many of the that are in cells cell and levels of nucleolin expression are generally to M. V. Scholar, M. Scholar). we have nucleolin as the molecular of a of that the of and leukemia cell and have significant as therapeutic agents J. 1999; Scholar, J. 2001; Scholar, V. 2002; Scholar, Blood. this we have described alterations in the levels and localization of nucleolin protein that in leukemia cells induced to undergo apoptosis by or treatment with the that induction of apoptosis by a in the levels of nuclear several by the of nucleolin from the containing plasma of nucleolin within the and the appearance of apoptotic containing nucleolin and PARP-1 were levels and localization of nucleolin in to apoptosis-induced changes, we have that alterations in nucleolin in the apoptotic at UV irradiation of cells fragmentation of DNA is on and of PARP-1 been the levels of nuclear nucleolin are a in the of nuclear nucleolin can be and levels of apoptotic can be detected and and data The that alterations in nucleolin are such an may indicate that this protein plays an role in the or of apoptosis, be to have been several that have examined the role of nucleolin in cell M. J. Cell. Scholar, M. G. J. Cell. 2001; Scholar, M. G. P. J. Cell. 2001; have and to examine changes in proteins in leukemia cells treated with camptothecin or These a with fragmentation of of nucleolin in apoptotic cells cells, and that nucleolin during apoptosis, in with our In to our results and of and several that nucleolin is in response to S. J. to nucleolin as a protein that cleaved in response to apoptosis in a cell S. J. Med. 2001; described the proteolysis of a protein to be to a or cells were treated with J. that nucleolin a for by an by The findings apoptosis-induced of nucleolin could be caused by cell death the apoptotic pathways for treatment are from it to that DNA as UV irradiation or camptothecin could a from which to S. J. Scholar), or which is to S. S. apoptosis-induced changes in nucleolin levels that we have described to in some as an inhibitor of PARP-1 can be to this is to of nucleolin by or the binding of nucleolin to the of PARP-1 In with our have described of PARP-1 in response to apoptosis G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar). PARP-1 can be in the some G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar, S. Scholar), and is some to that the is central to the of apoptosis and the of proteolysis M. G. V. M. J. J. J. 2001; Scholar, J. result of our study is the that nucleolin to be from apoptotic cells in the of bodies. J. described apoptotic in and several of have been M. FASEB J. Scholar, Z. Scholar). are thought to be from which are to the plasma and the are by Med. 2001; Scholar). apoptotic have been are to several DNA or plasma and nuclear proteins M. G. P. J. Cell. 2001; Scholar, Z. of nucleolin in apoptotic a of In apoptotic are by or cells, and from the of apoptosis, apoptotic may be the Med. 2001; and could be detected in plasma or This apoptosis can be caused by a of autoimmune and cancer. There is that the of apoptotic cells or can be an important or marker for several of Scholar, J. Scholar, 2002; Scholar, M. J. J. 2001; and of apoptotic or in been as a to the of or to therapeutic response in chemotherapy or S. P. M. J. 2001; Scholar, 2001; Scholar). Nucleolin may be a useful marker for apoptosis in apoptotic are to be rich in The of apoptotic to their to the cells that is an which been to the of M. S. 2001; 98: Scholar, J. G. Blood. 1999; and as a J. Reed J.M. 2002; data have for some autoimmune which are thought to at least in of defects in apoptotic P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar, Med. 2001; Scholar). are characterized by the development of and and is that this response could be by exposure of the to of from apoptotic cells G. J. Med. Scholar, Am. Scholar, M. S. P. J. 2001; Scholar, J. 2002; Scholar). The appearance of nucleolin autoantibodies is of the of the autoimmune systemic lupus erythematosus and are in some of the autoantibodies to as the S. J. Scholar, M. J. S. Scholar). that apoptotic containing nucleolin are from cells undergoing apoptosis a possible explanation for the appearance of nucleolin autoantibodies in with have a high of PARP-1 autoantibodies S. J. 2002; our have nucleolin as an important of the apoptotic in leukemia cells. we have role in this our results indicate that nucleolin may be involved in the of a of Furthermore, the nuclear of from the plasma and in apoptotic may be useful to apoptosis in and There are a of nucleolin and regulation is of nucleolin is a protein of and to within the the for have been (6Srivastava M. Pollard H.B. FASEB J. 1999; 13: 1911-1922Google Scholar, 7Ginisty P. J. 1999; Scholar, Scholar). nucleolin is associated with many of the that are in cells cell and levels of nucleolin expression are generally to M. V. Scholar, M. Scholar). we have nucleolin as the molecular of a of that the of and leukemia cell and have significant as therapeutic agents J. 1999; Scholar, J. 2001; Scholar, V. 2002; Scholar, Blood. Scholar). In this we have described alterations in the levels and localization of nucleolin protein that in leukemia cells induced to undergo apoptosis by or treatment with the that induction of apoptosis by a in the levels of nuclear several by the of nucleolin from the containing plasma of nucleolin within the and the appearance of apoptotic containing nucleolin and PARP-1 were levels and localization of nucleolin in to apoptosis-induced changes, we have that alterations in nucleolin in the apoptotic at UV irradiation of cells fragmentation of DNA is on and of PARP-1 been the levels of nuclear nucleolin are a in the of nuclear nucleolin can be and levels of apoptotic can be detected and and data The that alterations in nucleolin are such an may indicate that this protein plays an role in the or of apoptosis, be to have been several that have examined the role of nucleolin in cell M. J. Cell. Scholar, M. G. J. Cell. 2001; Scholar, M. G. P. J. Cell. 2001; have and to examine changes in proteins in leukemia cells treated with camptothecin or These a with fragmentation of of nucleolin in apoptotic cells cells, and that nucleolin during apoptosis, in with our In to our results and of and several that nucleolin is in response to S. J. to nucleolin as a protein that cleaved in response to apoptosis in a cell S. J. Med. 2001; described the proteolysis of a protein to be to a or cells were treated with J. that nucleolin a for by an by The findings apoptosis-induced of nucleolin could be caused by cell death the apoptotic pathways for treatment are from it to that DNA as UV irradiation or camptothecin could a from which to S. J. Scholar), or which is to S. S. Scholar). The apoptosis-induced changes in nucleolin levels that we have described to in some as an inhibitor of PARP-1 can be to this is to of nucleolin by or the binding of nucleolin to the of PARP-1 In with our have described of PARP-1 in response to apoptosis G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar). PARP-1 can be in the some G. M. 2001; Scholar, J. 2001; Scholar, M. J. 1999; Scholar, S. Scholar), and is some to that the is central to the of apoptosis and the of proteolysis M. G. V. M. J. J. J. 2001; Scholar, J. Scholar). result of our study is the that nucleolin to be from apoptotic cells in the of bodies. J. described apoptotic in and several of have been M. FASEB J. Scholar, Z. Scholar). are thought to be from which are to the plasma and the are by Med. 2001; Scholar). apoptotic have been are to several DNA or plasma and nuclear proteins M. G. P. J. Cell. 2001; Scholar, Z. Scholar). The of nucleolin in apoptotic a of In apoptotic are by or cells, and from the of apoptosis, apoptotic may be the Med. 2001; and could be detected in plasma or This apoptosis can be caused by a of autoimmune and cancer. There is that the of apoptotic cells or can be an important or marker for several of Scholar, J. Scholar, 2002; Scholar, M. J. J. 2001; and of apoptotic or in been as a to the of or to therapeutic response in chemotherapy or S. P. M. J. 2001; Scholar, 2001; Scholar). Nucleolin may be a useful marker for apoptosis in apoptotic are to be rich in The of apoptotic to their to the cells that is an which been to the of M. S. 2001; 98: Scholar, J. G. Blood. 1999; and as a J. Reed J.M. 2002; Scholar). data have for some autoimmune which are thought to at least in of defects in apoptotic P. Dong Z. Mikhailov V. Denton M. Weinberg J.M. Venkatachalam M.A. Am. J. Med. 1999; 107: 489-506Google Scholar, Med. 2001; Scholar). are characterized by the development of and and is that this response could be by exposure of the to of from apoptotic cells G. J. Med. Scholar, Am. Scholar, M. S. P. J. 2001; Scholar, J. 2002; Scholar). The appearance of nucleolin autoantibodies is of the of the autoimmune systemic lupus erythematosus and are in some of the autoantibodies to as the S. J. Scholar, M. J. S. Scholar). that apoptotic containing nucleolin are from cells undergoing apoptosis a possible explanation for the appearance of nucleolin autoantibodies in with have a high of PARP-1 autoantibodies S. J. 2002; Scholar). In our have nucleolin as an important of the apoptotic in leukemia cells. we have role in this our results indicate that nucleolin may be involved in the of a of Furthermore, the nuclear of from the plasma and in apoptotic may be useful to apoptosis in and Z. and for of the
57
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
Damien D’Amours, Serge Desnoyers, Icy D’Silva et al. · Biochemical Journal · 1999 · 1.8K citations · Full text
Livia Casciola‐Rosen, Grant J. Anhalt, Antony Rosen · The Journal of Experimental Medicine · 1994 · 1.7K citations · Full text
Major nucleolar proteins shuttle between nucleus and cytoplasm
R.A. Borer, Christian F. Lehner, Hans M. Eppenberger et al. · Cell · 1989 · 1.1K citations